EU's medicine watchdog approves vaccine specifically targeting the new and contagious BA.4 and BA.5 types of the Omicron variant amid fears of a new wave of Covid-19 winter infections
The"bivalent" jab, made by Pfizer/BioNTech, is directed at the highly infectious BA.4 and BA.5 types of the variant.
Approved on Monday, the so-called "bivalent" jab, made by Pfizer/BioNTech, is directed at the highly infectious BA.4 and BA.5 types of the variant and is the first of its kind to be approved within the 27-nation bloc. The latest shot is aimed at people over 12 and who have already received at least one primary vaccination against the coronavirus, and it is an adaptive version of Pfizer's original Comirnaty vaccine.
The EMA's recommendation - which will now be sent to the European Commission for a final decision - was specifically based on clinical data from Pfizer's vaccines aimed at the original virus and the Omicron BA.1 variant."Apart from containing mRNA matching different, but closely related, Omicron sub-variants, Comirnaty Original/Omicron BA.4-5 and Comirnaty Original/Omicron BA.1 have the same composition," the EMA said.
When a person then comes in contact with the real virus, the body's immune system will also recognise and attack it.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
University Health to begin offering Pfizer-BioNTech bivalent COVID-19 vaccine this weekUniversity Health will begin offering the Pfizer-BioNTech bivalent COVID-19 vaccine starting Tuesday to provide a new layer of protection against the Omicron variant.
Lire la suite »
LA County’s COVID hospitalizations continue to plateauThe county this week began offering the recently approved COVID vaccine booster shot that targets the Omicron variants of the virus.
Lire la suite »
Should I Get the New COVID Booster?The booster shot, also referred to as a “bivalent” booster, was redesigned in hopes it would more specifically target Omicron subvariants, now the dominant form of COVID in the U.S.
Lire la suite »
CDC rolls out new vaccine booster to target Omicron variant ahead of the fall seasonThe Center for Disease Control and Prevention is recommending an additional COVID-19 booster shot that targets the Omicron variant.
Lire la suite »